Building trust and collaboration with patient advocacy organisations
Critical success factors for rare disease clinical trials
Although China’s regulatory reforms have attracted many foreign companies to conduct trials in China, there are still challenges.
Expertise in mission-critical pricing, market access, and reimbursement.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.